Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (601-610 of 777) with videos related to

Pageof 78
Sort By:
Alimentary Pharmacology & Therapeutics|March 14, 2024
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver diseaseNina Dominik, Bernhard Scheiner, Alberto Zanetto, et al.
BMJ Open|June 26, 2024
Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitisNasir Hussain, Christopher Ma, Gideon Hirschfield, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Hepatology (Baltimore, Md.)|September 11, 2019
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing CholangitisMatteo Tardelli, Francesca V Bruschi, Claudia D Fuchs, et al.
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Journal of Hepatology|June 19, 2016
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatmentKarin Kozbial, Stephan Moser, Remy Schwarzer, et al.
European Radiology|July 20, 2023
Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept studySarah Poetter-Lang, Alina Messner, Nina Bastati, et al.
European Radiology|June 26, 2023
Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept studyNina Bastati, Matthias Perkonigg, Daniel Sobotka, et al.
Pageof 78

Showing results (601-610 of 777) with videos related to

Sort By:
Pageof 78
Alimentary Pharmacology & Therapeutics|March 14, 2024
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver diseaseNina Dominik, Bernhard Scheiner, Alberto Zanetto, et al.
BMJ Open|June 26, 2024
Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitisNasir Hussain, Christopher Ma, Gideon Hirschfield, et al.
United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Hepatology (Baltimore, Md.)|September 11, 2019
Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing CholangitisMatteo Tardelli, Francesca V Bruschi, Claudia D Fuchs, et al.
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Journal of Hepatology|June 19, 2016
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatmentKarin Kozbial, Stephan Moser, Remy Schwarzer, et al.
European Radiology|July 20, 2023
Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept studySarah Poetter-Lang, Alina Messner, Nina Bastati, et al.
European Radiology|June 26, 2023
Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept studyNina Bastati, Matthias Perkonigg, Daniel Sobotka, et al.
Pageof 78